Literature DB >> 30879940

Quantification of coronary artery disease using different modalities of cardiopulmonary exercise testing.

Dejana Popovic1, Marco Guazzi2, Djordje G Jakovljevic3, Ratko Lasica4, Marko Banovic4, Miodrag Ostojic4, Ross Arena5.   

Abstract

BACKGROUND: This study examined the accuracy of cardiopulmonary exercise testing (CPET) on a treadmill (TM) and recumbent ergometry (RE) in the predicting coronary artery disease (CAD) severity and prognosis.
METHODS: Forty Caucasian subjects, mean age 63.5 ± 7.6, with significant coronary artery lesions (≥50%) were included. Within two months of coronary angiography, TM and RE CPET were performed on two visits 2-4 days apart and subsequently followed up to 32 ± 10 months.
RESULTS: Mean left ventricular ejection fraction was 56.7 ± 9.6%. TM CPET exhibited a higher occurrence of ST segment depression ≥ 1 mm (71.05% vs 28.95%, p = 0.04). Subjects with 1-2 stenotic coronary arteries (SCA) demonstrated a better CPET response compared to those with 3-SCA. ROC analysis revealed a high predictive value for the ventilation/carbon dioxide production (VE/VCO2) slope obtained on TM (area 0.84, p = 0.003, Sn 88.9%, Sp 72%) in distinguishing between 1 and 2-SCA and 3-SCA. Among all CPET parameters, work efficiency (∆VO2/∆WR) during RE predicted cumulative cardiac events (p < 0.01).
CONCLUSIONS: CPET parameters hold predictive value for CAD severity and prognosis. CPET on a TM appears to be more reliable in the quantification of CAD compared to RE.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID: 30879940     DOI: 10.1016/j.ijcard.2019.03.012

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Exercise capacity remains supernormal, though mildly reduced in middle-aged military personnel with Moderate to Severe Obstructive Sleep Apnea.

Authors:  Subodh K Arora; Tyler A Powell; Shannon N Foster; Shana L Hansen; Michael J Morris
Journal:  Sleep Breath       Date:  2022-02-25       Impact factor: 2.816

2.  Alpha-melanocyte-stimulating hormone during exercise recovery has prognostic value for coronary artery disease.

Authors:  Dejana Vidojevic; Stefan Seman; Ratko Lasica; Milorad Tesic; Marija Saric Matutinovic; Snezana Jovicic; Svetlana Ignjatovic; Ross Arena; Svetozar Damjanovic; Dejana Popovic
Journal:  Hormones (Athens)       Date:  2021-02-01       Impact factor: 2.885

3.  The Value of Cardiopulmonary Exercise Testing in Predicting the Severity of Coronary Artery Disease.

Authors:  Wanjun Liu; Xiaolei Liu; Tao Liu; Yang Xie; Xingwei He; Houjuan Zuo; Hesong Zeng
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

4.  Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.

Authors:  Sashiananthan Ganesananthan; Christopher A Rajkumar; Michael Foley; David Thompson; Alexandra N Nowbar; Henry Seligman; Ricardo Petraco; Sayan Sen; Sukhjinder Nijjer; Simon A Thom; Roland Wensel; John Davies; Darrel Francis; Matthew Shun-Shin; James Howard; Rasha Al-Lamee
Journal:  Eur Heart J       Date:  2022-09-01       Impact factor: 35.855

5.  Relating cardiorespiratory responses to work rate during incremental ramp exercise on treadmill in children and adolescents: sex and age differences.

Authors:  Nicola Lai; Justin J Fiutem; Nora Pfaff; Desy Salvadego; James Strainic
Journal:  Eur J Appl Physiol       Date:  2021-06-18       Impact factor: 3.078

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.